Nelson Vergel
Founder, ExcelMale.com
Curated By Nelson Vergel | ExcelMale.com | Updated June 2026
If you are on testosterone replacement therapy (TRT) or have used anabolic-androgenic steroids (AAS) and now want to start a family, you are not alone. Sperm production is one of the first casualties of exogenous androgen use - and it is also one of the most recoverable, if you act with the right information and the right medical support.
The data are sobering. Testosterone suppresses spermatogenesis in up to 90% of users. Azoospermia - zero detectable sperm - can develop within as few as ten weeks of starting TRT. But here is the important counterpoint: for most men, fertility is not permanently lost. With evidence-based pharmacological protocols, the majority of men can restore meaningful sperm counts within four to twelve months, and some accomplish this without even stopping testosterone.
This guide synthesizes the latest clinical research with practical protocols drawn from over two decades of discussion in the ExcelMale community. Whether you are trying to conceive now or planning ahead, understanding how androgen-induced infertility works - and how to reverse it - is the first step.
Under normal conditions, the hypothalamus pulses gonadotropin-releasing hormone (GnRH) to the pituitary, which responds by releasing two hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH travels to the Leydig cells in the testes, where it triggers local testosterone synthesis. FSH simultaneously activates Sertoli cells, which serve as the nursery environment for developing sperm. The internal testosterone concentration inside the testes - called intratesticular testosterone (ITT) - runs 50 to 100 times higher than serum levels, and this concentrated environment is a biological requirement for spermatogenesis.
When you introduce exogenous testosterone, the HPG axis detects an apparent hormone surplus. The hypothalamus and pituitary interpret this as a stop signal and shut down GnRH, LH, and FSH. Without LH stimulation, the Leydig cells go dormant and ITT collapses by up to 94%. Without FSH and adequate ITT, Sertoli cells can no longer support sperm maturation. The result is oligospermia (low sperm count) or azoospermia (no sperm at all).
This is one reason many clinicians and experienced men in our community add HCG to TRT from the start. HCG acts as an LH analog, keeping the Leydig cells active and maintaining ITT even when the pituitary has gone silent - preventing the atrophy from occurring in the first place.
AAS use - particularly "stacking" multiple compounds at supraphysiologic doses - imposes a deeper, more prolonged suppression. The medical literature recognizes a distinct condition called Anabolic Steroid-Induced Hypogonadism (ASIH). Men with ASIH who stop using AAS face a severe symptomatic gap - sometimes called the "zombie phase" - characterized by profound fatigue, muscle loss, low mood, and sexual dysfunction. The risk of relapse to AAS use to escape these symptoms is documented: one retrospective study found 33% of men restarted AAS within eight months of cessation, typically when spermatogenesis recovery was just beginning.
This is why pharmacological support during the recovery window is not optional for many men - it is the bridge that makes completion of a recovery protocol realistic.
Data from WHO male contraceptive trials - which used physiologic-to-modestly-supraphysiologic testosterone dosing for under two years - show the following spontaneous recovery rates after cessation:
These figures apply to physiologic TRT durations. AAS users at supraphysiologic doses, or men on long-term TRT, should expect recovery to fall toward the longer end of these windows - or require active pharmacological intervention to reach it at all. A 2022 European Journal of Endocrinology study found that after two years of injectable testosterone undecanoate, full reproductive hormone recovery took over 15 months and may not be complete at 12 months.
With combination treatment - specifically HCG plus FSH or HCG plus a SERM - the picture improves dramatically. A 2015 case series (Hsieh et al.) found the average time to return of spermatogenesis was just 4.6 months, with a mean first density of 22.6 million/mL, and 95.9% of azoospermic or severely oligospermic men responded.
Important note for AAS users: If you are planning a vasectomy reversal, a 3-month lead time on a testicular salvage protocol (HCG +/- FSH) is recommended before surgery. Sperm availability at the surgical anastomosis site is a primary predictor of long-term surgical success, and pharmacological priming significantly improves that outcome.
A foundational 2005 study by Coviello et al. demonstrated that TRT alone drops ITT by 94%. Adding subcutaneous HCG at 250 IU every other day prevented nearly all of that decline (ITT fell only 7%). At 500 IU every other day, ITT actually increased 26% above baseline. The practical implication: for fertility restoration, doses well above 250 IU are typically required.
For active restoration (when you have stopped TRT and want sperm back quickly), doses range from 1,000 to 3,000 IU three times per week. Higher doses - up to 5,000 or 10,000 IU three times weekly - have been used in severe ASIH cases. Dosing should be titrated based on the testosterone response and semen analysis results every two months.
Important regulatory note: Following a 2025 FDA reclassification, HCG is now classified as a biologic. This significantly restricts access through compounding pharmacies. Branded products such as Pregnyl are the primary route to access. Discuss current availability with your prescribing physician.
A 2024 study published in Fertility and Sterility (Kannady et al.) followed 77 men with prior testosterone use treated with 3,000 IU HCG and 75 IU FSH three times weekly. The results: 74% showed improved sperm concentrations. Notably, men who stayed on testosterone during the protocol had identical recovery rates to those who stopped - a finding with significant implications for men who cannot or choose not to discontinue TRT.
Another review found that FSH combined with HCG resulted in sperm returning to the ejaculate in an average of 6.4 months versus 14.8 months for HCG combined with clomiphene - a meaningful difference for couples with fertility timelines. Men who fail HCG + clomiphene as a first attempt and switch to HCG + FSH show approximately 73% pregnancy rates, underscoring FSH as a strong second-line escalation.
Clomiphene citrate (Clomid) at 25-50 mg daily or on alternate days is the most commonly used SERM in recovery protocols. It can be layered onto HCG therapy to boost FSH levels when rFSH is unavailable or cost-prohibitive.
Enclomiphene - the trans-isomer of clomiphene - is increasingly preferred in clinical practice. Standard clomiphene contains a second isomer, zuclomiphene, which has estrogenic activity and can cause side effects including mood changes and, in some men, visual disturbances. Enclomiphene provides the hypothalamic reboot without these estrogenic effects. A 2023 retrospective study from the University of Miami found enclomiphene performed similarly to clomiphene for restoring sperm parameters, with a cleaner side effect profile.
Clinical evidence shows AI adjunction improves outcomes in approximately 77% of men where the T:E ratio is below the threshold. However, over-suppression of estradiol carries its own risks - including bone density loss and cardiovascular impact - so AI use requires regular monitoring and precise titration.
The traditional clinical position - reflected in 2018 guidelines from both the American Urological Association and the Endocrine Society - is that TRT should be discontinued if fertility is desired. However, the landmark 2024 Fertility and Sterility study challenges this stance directly. In a cohort of 77 men treated with HCG + FSH, those who stayed on testosterone during the protocol had identical recovery rates (74% improved sperm concentrations) as those who stopped TRT.
The ExcelMale community has documented many men who successfully restored fertility after years on TRT, in some cases while staying on testosterone throughout the process. One longtime member reported that HCG, HMG, and FSH restored his fertility after 27 years on testosterone and other anabolic steroids.
That said, staying on TRT during a fertility recovery protocol requires experienced medical supervision. The HCG and FSH doses required are typically higher than maintenance doses, and careful semen analysis monitoring every two months is essential to confirm progress. Men who do not respond adequately on TRT + HCG + FSH may need to stop testosterone to allow the pituitary to resume its own LH and FSH output.
If you are not yet on TRT and are considering starting but want to preserve future fertility options, the most conservative and reliable approach is to bank sperm before you begin. This eliminates uncertainty about future recovery timelines.
Critical timing note: Do not begin HCG until exogenous androgens have substantially cleared your system. Allow approximately 5-7 days after the last injection of short-acting esters (cypionate, enanthate). Longer-acting esters or AAS may require 2-4 weeks of clearance before initiating the protocol.
For men with deeper suppression (long-duration AAS use, severe ASIH, or prior failed recovery), the protocol may be extended and HCG doses escalated to 3,000 IU or higher during the initial phase, combined with rFSH 75 IU three times weekly. Semen analysis should be performed at the start of the protocol and every two months thereafter to assess response.
The ASIH "zombie phase" - the window between stopping androgens and when the HPG axis begins to recover - is the highest-risk period for protocol abandonment. Patients who restart AAS or TRT during this window reset the fertility clock. Proactive symptom management through the protocol itself, along with physician support, is the most effective strategy for bridging this gap.
DiscountedLabs.com offers a post-PCT panel that covers the key markers in a single draw. Having baseline values before the protocol starts is critical for tracking progress and making decisions about dose escalation or adding FSH.
If sperm counts fail to improve after three to four months despite adequate testosterone response to HCG, this is a signal to either escalate to HCG + rFSH, or - if still on TRT - to discontinue testosterone and allow endogenous pituitary function to resume.
• Sleep: Testosterone production is heavily dependent on sleep quality and quantity. Seven to nine hours of uninterrupted sleep is non-negotiable during HPG axis recovery. Even mild sleep restriction reduces LH pulse amplitude overnight.
• Exercise: Moderate aerobic activity (150 minutes per week) and twice-weekly resistance training support metabolic health and mood without over-stressing the HPA axis. Avoid excessive endurance training, which can suppress the HPG axis independently.
• Zinc: At 30-50 mg daily, zinc is specifically relevant for men with marginal deficiency. Zinc is a co-factor in testosterone biosynthesis and sperm maturation. Do not megadose without testing for deficiency first.
• Vitamin D: Deficiency is directly associated with lower testosterone and impaired steroidogenesis. Target serum 25-OH-D levels of 50-80 ng/mL during recovery; supplementation at 2,000-4,000 IU daily is appropriate for most deficient men.
• Heat avoidance: Spermatogenesis requires scrotal temperatures below core body temperature. Avoid hot baths, saunas, and prolonged laptop use on the lap during recovery.
• Alcohol and cannabis: Both suppress testosterone and directly impair sperm quality. Minimizing or eliminating use during the recovery window is advisable.
• How Does HCG Therapy Restore Sperm Production After TRT Suppresses It? - A detailed breakdown of the 2024 Fertility and Sterility data and dosing evidence, including the landmark finding that staying on TRT does not impede HCG/FSH recovery.
• Fertility Maintenance or Restoration in Men Before, During, and After TRT or AAS - Comprehensive review covering prevention, maintenance, and active restoration protocols based on published clinical guidelines.
• How to Improve Sperm Quality, LH, FSH and Testosterone in Infertile Men - First-hand community accounts from men who restored fertility using HCG, HMG, and FSH protocols, including cases involving decades of TRT.
• Best HCG Dose for Men on TRT: Two Studies That Used HCG with Testosterone - Evidence review showing why 500 IU (not 250 IU) is the minimum dose to maintain intratesticular testosterone while on TRT.
• Clomid to Reset Hormonal Axis After Anabolic Steroids - Discusses the first published case of clomiphene successfully restoring testosterone and pituitary-gonadal axis function after multi-anabolic steroid abuse.
• HPTA Restart in Young Men After Anabolic Steroids - Specific guidance and community discussion for younger men (under 35) seeking hormonal recovery after AAS use.
• How to Stop Testosterone or Anabolics Safely - What PCT Programs Work? - Extensive thread covering multiple PCT frameworks including the Dr. Scally protocol, with community member recovery logs.
• Regaining Fertility After 3 Years TRT - Real member experiences navigating fertility protocols after extended TRT use, including practical observations on HCG dosing and timing.
• Why Use HCG with TRT? A Clinical Review - In-depth overview of the HPG mechanisms behind HCG's role in TRT, including evidence on ITT maintenance, testicular atrophy prevention, and fertility outcomes.
2. Hsieh TC, et al. Concomitant Intramuscular Human Chorionic Gonadotropin Preserves Spermatogenesis in Men Undergoing Testosterone Replacement Therapy. Journal of Urology. 2013. DOI: 10.1016/j.juro.2012.08.084 [Link]
3. Coviello AD, et al. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression. Journal of Clinical Endocrinology and Metabolism. 2005. DOI: 10.1210/jc.2004-0802 [Link]
4. Kannady C, et al. Optimal Restoration of Spermatogenesis After Testosterone Therapy Using Human Chorionic Gonadotropin and Follicle-Stimulating Hormone. Fertility and Sterility. 2024. DOI: 10.1016/j.fertnstert.2024.08.358 [Link]
5. Kohn TP, et al. Fertility Outcomes After Testosterone Replacement Therapy or Anabolic Steroid Abuse. Journal of Urology. 2018. DOI: 10.1016/j.juro.2017.10.019 [Link]
6. Handelsman DJ, et al. Recovery of Male Reproductive Function After Ceasing Prolonged Testosterone Undecanoate Injections. European Journal of Endocrinology. 2022. DOI: 10.1530/EJE-21-0608 [Link]
7. Thomas J, et al. Efficacy of Clomiphene Citrate Versus Enclomiphene Citrate for Male Infertility Treatment: A Retrospective Study. Cureus. 2023. DOI: 10.7759/cureus.41476 [Link]
8. Ramasamy R, et al. Factors Predicting Normalization of Reproductive Hormones After Cessation of AAS in Men. World Journal of Men's Health. 2019. DOI: 10.5534/wjmh.190002 [Link]
9. Injac R. Spermatogenesis Recovery Treatment in Less Than Four Months After Several Cycles of Steroids. Clinical Case Reports. 2023. DOI: 10.1002/ccr3.8159 [Link]
10. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive Efficacy of Testosterone-Induced Azoospermia in Normal Men. Lancet. 1990. [Link]
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy, fertility protocol, or medical treatment. The protocols described here are based on published clinical literature and should be implemented only under physician supervision, with appropriate laboratory monitoring.
About ExcelMale.com
ExcelMale.com is the leading expert-moderated men's health forum, with over 24,000 members and a 20-year archive of evidence-based discussion on testosterone replacement therapy, hormone optimization, peptides, sexual health, and metabolic wellness. Founded by Nelson Vergel - chemical engineer, 34-year TRT patient, and patient advocate - the community bridges clinical research with real-world patient experience.
Nelson is the author of Testosterone: A Man's Guide and Beyond Testosterone, both available on Amazon. For laboratory testing, visit DiscountedLabs.com for affordable male hormone and fertility panels.
If you are on testosterone replacement therapy (TRT) or have used anabolic-androgenic steroids (AAS) and now want to start a family, you are not alone. Sperm production is one of the first casualties of exogenous androgen use - and it is also one of the most recoverable, if you act with the right information and the right medical support.
The data are sobering. Testosterone suppresses spermatogenesis in up to 90% of users. Azoospermia - zero detectable sperm - can develop within as few as ten weeks of starting TRT. But here is the important counterpoint: for most men, fertility is not permanently lost. With evidence-based pharmacological protocols, the majority of men can restore meaningful sperm counts within four to twelve months, and some accomplish this without even stopping testosterone.
This guide synthesizes the latest clinical research with practical protocols drawn from over two decades of discussion in the ExcelMale community. Whether you are trying to conceive now or planning ahead, understanding how androgen-induced infertility works - and how to reverse it - is the first step.
Key Takeaways • TRT and anabolic steroids suppress the HPG axis, halting sperm production in up to 90% of users. • Azoospermia can develop within 10 weeks of starting TRT; spontaneous recovery without treatment can take 1-2 years. • HCG is the gold standard first-line agent for restoring sperm production. Adding FSH or a SERM accelerates recovery. • A landmark 2024 Fertility and Sterility study found 74% of men improved sperm counts with HCG + FSH - even while staying on testosterone. • Average time to return of spermatogenesis with combination therapy is approximately 4.6 months. • Sperm banking before starting TRT remains the most reliable insurance policy for men who may want children later. • Blood tests (LH, FSH, total testosterone, estradiol, semen analysis every 2 months) are essential to guide protocol adjustment. |
How Do Testosterone and Anabolic Steroids Suppress Sperm Production?
To understand why fertility fails on exogenous androgens, you need to understand the hypothalamic-pituitary-gonadal (HPG) axis - the three-station communication network that governs both testosterone and sperm production.Under normal conditions, the hypothalamus pulses gonadotropin-releasing hormone (GnRH) to the pituitary, which responds by releasing two hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH travels to the Leydig cells in the testes, where it triggers local testosterone synthesis. FSH simultaneously activates Sertoli cells, which serve as the nursery environment for developing sperm. The internal testosterone concentration inside the testes - called intratesticular testosterone (ITT) - runs 50 to 100 times higher than serum levels, and this concentrated environment is a biological requirement for spermatogenesis.
When you introduce exogenous testosterone, the HPG axis detects an apparent hormone surplus. The hypothalamus and pituitary interpret this as a stop signal and shut down GnRH, LH, and FSH. Without LH stimulation, the Leydig cells go dormant and ITT collapses by up to 94%. Without FSH and adequate ITT, Sertoli cells can no longer support sperm maturation. The result is oligospermia (low sperm count) or azoospermia (no sperm at all).
What Happens to the Testes When the HPG Axis Shuts Down?
Beyond sperm production, the physical structure of the testes changes. Since 80% of testicular volume consists of germinal epithelium and seminiferous tubules - the tissue that produces sperm - the loss of spermatogenic activity leads to visible testicular atrophy. Studies show that testicular size correlates directly with the duration of androgen use, and some research suggests the atrophy may not fully reverse even years after stopping AAS, even when testosterone levels normalize.This is one reason many clinicians and experienced men in our community add HCG to TRT from the start. HCG acts as an LH analog, keeping the Leydig cells active and maintaining ITT even when the pituitary has gone silent - preventing the atrophy from occurring in the first place.
Is There a Difference Between TRT-Induced Suppression and AAS-Induced Suppression?
Yes, and the difference matters clinically. TRT typically involves stable, physiologic doses of a single ester. While it reliably suppresses the HPG axis and causes azoospermia in the majority of users, the axis generally remains pharmacologically responsive once exogenous androgens clear the system.AAS use - particularly "stacking" multiple compounds at supraphysiologic doses - imposes a deeper, more prolonged suppression. The medical literature recognizes a distinct condition called Anabolic Steroid-Induced Hypogonadism (ASIH). Men with ASIH who stop using AAS face a severe symptomatic gap - sometimes called the "zombie phase" - characterized by profound fatigue, muscle loss, low mood, and sexual dysfunction. The risk of relapse to AAS use to escape these symptoms is documented: one retrospective study found 33% of men restarted AAS within eight months of cessation, typically when spermatogenesis recovery was just beginning.
This is why pharmacological support during the recovery window is not optional for many men - it is the bridge that makes completion of a recovery protocol realistic.
How Long Does It Take to Restore Sperm Production After Stopping TRT or Anabolic Steroids?
Recovery timelines depend on multiple factors: how long you used exogenous androgens, what compounds and doses were involved, your age, and whether you pursue pharmacological support or wait for spontaneous recovery. The baseline expectation without treatment is three to six months before sperm even begin to reappear, and potentially much longer before counts normalize.Data from WHO male contraceptive trials - which used physiologic-to-modestly-supraphysiologic testosterone dosing for under two years - show the following spontaneous recovery rates after cessation:
Recovery Milestone | Sperm Concentration | Probability of Reaching It |
6 months | 20 million/mL (WHO lower reference) | 67% |
12 months | 20 million/mL | 90% |
16 months | 20 million/mL | 96% |
24 months | 20 million/mL | 100% |
These figures apply to physiologic TRT durations. AAS users at supraphysiologic doses, or men on long-term TRT, should expect recovery to fall toward the longer end of these windows - or require active pharmacological intervention to reach it at all. A 2022 European Journal of Endocrinology study found that after two years of injectable testosterone undecanoate, full reproductive hormone recovery took over 15 months and may not be complete at 12 months.
With combination treatment - specifically HCG plus FSH or HCG plus a SERM - the picture improves dramatically. A 2015 case series (Hsieh et al.) found the average time to return of spermatogenesis was just 4.6 months, with a mean first density of 22.6 million/mL, and 95.9% of azoospermic or severely oligospermic men responded.
Important note for AAS users: If you are planning a vasectomy reversal, a 3-month lead time on a testicular salvage protocol (HCG +/- FSH) is recommended before surgery. Sperm availability at the surgical anastomosis site is a primary predictor of long-term surgical success, and pharmacological priming significantly improves that outcome.
What Medications Are Used to Restore Spermatogenesis After TRT or Anabolic Steroids?
A multi-agent approach consistently outperforms monotherapy. The goal is to simultaneously stimulate the dormant testes directly and restore or unblock the pituitary signaling that drives endogenous sperm production. Here are the tools available:How Does HCG Restart Sperm Production?
Human chorionic gonadotropin (HCG) is the cornerstone of every spermatogenesis restoration protocol. It is structurally similar to LH and binds directly to LH receptors on Leydig cells, triggering endogenous testosterone production inside the testes. Its clinical advantage over native LH is its 36-hour half-life, versus LH's 30-minute half-life - making it far more practical to administer.A foundational 2005 study by Coviello et al. demonstrated that TRT alone drops ITT by 94%. Adding subcutaneous HCG at 250 IU every other day prevented nearly all of that decline (ITT fell only 7%). At 500 IU every other day, ITT actually increased 26% above baseline. The practical implication: for fertility restoration, doses well above 250 IU are typically required.
For active restoration (when you have stopped TRT and want sperm back quickly), doses range from 1,000 to 3,000 IU three times per week. Higher doses - up to 5,000 or 10,000 IU three times weekly - have been used in severe ASIH cases. Dosing should be titrated based on the testosterone response and semen analysis results every two months.
Important regulatory note: Following a 2025 FDA reclassification, HCG is now classified as a biologic. This significantly restricts access through compounding pharmacies. Branded products such as Pregnyl are the primary route to access. Discuss current availability with your prescribing physician.
When Is FSH Added to the Protocol?
HCG alone addresses the LH deficiency but does not directly stimulate FSH receptors on Sertoli cells. For men who need to maximize sperm quantity and quality - particularly those with longstanding suppression - adding recombinant FSH (rFSH) is often necessary.A 2024 study published in Fertility and Sterility (Kannady et al.) followed 77 men with prior testosterone use treated with 3,000 IU HCG and 75 IU FSH three times weekly. The results: 74% showed improved sperm concentrations. Notably, men who stayed on testosterone during the protocol had identical recovery rates to those who stopped - a finding with significant implications for men who cannot or choose not to discontinue TRT.
Another review found that FSH combined with HCG resulted in sperm returning to the ejaculate in an average of 6.4 months versus 14.8 months for HCG combined with clomiphene - a meaningful difference for couples with fertility timelines. Men who fail HCG + clomiphene as a first attempt and switch to HCG + FSH show approximately 73% pregnancy rates, underscoring FSH as a strong second-line escalation.
What Role Do SERMs Like Clomiphene and Enclomiphene Play?
Selective estrogen receptor modulators (SERMs) work at the hypothalamic level. By blocking estrogen receptors in the brain, they create a false signal of low estrogen, prompting the hypothalamus to ramp up GnRH secretion and the pituitary to increase LH and FSH output. This "system reboot" complements the direct testicular stimulation of HCG.Clomiphene citrate (Clomid) at 25-50 mg daily or on alternate days is the most commonly used SERM in recovery protocols. It can be layered onto HCG therapy to boost FSH levels when rFSH is unavailable or cost-prohibitive.
Enclomiphene - the trans-isomer of clomiphene - is increasingly preferred in clinical practice. Standard clomiphene contains a second isomer, zuclomiphene, which has estrogenic activity and can cause side effects including mood changes and, in some men, visual disturbances. Enclomiphene provides the hypothalamic reboot without these estrogenic effects. A 2023 retrospective study from the University of Miami found enclomiphene performed similarly to clomiphene for restoring sperm parameters, with a cleaner side effect profile.
Are Aromatase Inhibitors Needed?
Aromatase inhibitors (AIs) like anastrozole or letrozole are strictly adjunctive tools, not primary recovery agents. As testosterone levels rise during HCG therapy, aromatization to estradiol increases. If the testosterone-to-estrogen ratio falls below 10:1, elevated estradiol creates its own form of pituitary suppression, blunting the recovery effect. An AI corrects this hormonal imbalance and is indicated when estradiol is disproportionately elevated relative to testosterone.Clinical evidence shows AI adjunction improves outcomes in approximately 77% of men where the T:E ratio is below the threshold. However, over-suppression of estradiol carries its own risks - including bone density loss and cardiovascular impact - so AI use requires regular monitoring and precise titration.
Agent | Mechanism | Typical Recovery Dose | Primary Role |
HCG | LH analog - stimulates Leydig cells, restores ITT | 1,000-3,000 IU 3x/week | First-line for ITT and Leydig cell reactivation |
rFSH | Direct FSH signal to Sertoli cells | 75 IU 3x/week | Added when HCG alone is insufficient |
Clomiphene | SERM - blocks hypothalamic estrogen receptor, raises LH/FSH | 25-50 mg daily or alternate days | Hypothalamic reboot; can pair with HCG |
Enclomiphene | Pure anti-estrogen SERM isomer, no estrogenic activity | 12.5-25 mg daily | Preferred SERM with cleaner side effect profile |
Aromatase Inhibitor | Blocks T-to-E2 conversion, improves T:E ratio | Anastrozole 0.5-1 mg 2x/week | Adjunct when T:E ratio falls below 10:1 |
Do I Have to Stop Testosterone to Restore My Fertility?
This is one of the most frequently asked questions in our community, and the answer has shifted meaningfully with recent evidence.The traditional clinical position - reflected in 2018 guidelines from both the American Urological Association and the Endocrine Society - is that TRT should be discontinued if fertility is desired. However, the landmark 2024 Fertility and Sterility study challenges this stance directly. In a cohort of 77 men treated with HCG + FSH, those who stayed on testosterone during the protocol had identical recovery rates (74% improved sperm concentrations) as those who stopped TRT.
The ExcelMale community has documented many men who successfully restored fertility after years on TRT, in some cases while staying on testosterone throughout the process. One longtime member reported that HCG, HMG, and FSH restored his fertility after 27 years on testosterone and other anabolic steroids.
That said, staying on TRT during a fertility recovery protocol requires experienced medical supervision. The HCG and FSH doses required are typically higher than maintenance doses, and careful semen analysis monitoring every two months is essential to confirm progress. Men who do not respond adequately on TRT + HCG + FSH may need to stop testosterone to allow the pituitary to resume its own LH and FSH output.
If you are not yet on TRT and are considering starting but want to preserve future fertility options, the most conservative and reliable approach is to bank sperm before you begin. This eliminates uncertainty about future recovery timelines.
What Is the Standard 8-Week Recovery Protocol After Stopping TRT or Anabolic Steroids?
For men discontinuing TRT or ending an AAS cycle, the following protocol provides a structured framework for HPG axis recovery. This approach is widely referenced in the clinical literature and has been implemented by physicians at leading men's health and fertility centers. Individual doses and duration should be confirmed with your prescribing physician.Critical timing note: Do not begin HCG until exogenous androgens have substantially cleared your system. Allow approximately 5-7 days after the last injection of short-acting esters (cypionate, enanthate). Longer-acting esters or AAS may require 2-4 weeks of clearance before initiating the protocol.
Phase | Duration | HCG Dose | SERM / Adjunct | Goal |
Phase 1 | Weeks 1-2 | 1,000 IU subcutaneous, 3x/week | None | Reactivate Leydig cells; restore ITT |
Phase 2 | Weeks 3-4 | 500 IU subcutaneous, 3x/week | None | Sustain ITT at lower maintenance dose |
Phase 3 | Weeks 5-6 | 250 IU subcutaneous, 3x/week | Clomiphene 50 mg alternate days | Bridge to pituitary reactivation via SERM |
Phase 4 | Weeks 7-8 | Discontinue HCG | Clomiphene 50 mg alternate days | Full SERM-driven endogenous LH/FSH recovery |
For men with deeper suppression (long-duration AAS use, severe ASIH, or prior failed recovery), the protocol may be extended and HCG doses escalated to 3,000 IU or higher during the initial phase, combined with rFSH 75 IU three times weekly. Semen analysis should be performed at the start of the protocol and every two months thereafter to assess response.
The ASIH "zombie phase" - the window between stopping androgens and when the HPG axis begins to recover - is the highest-risk period for protocol abandonment. Patients who restart AAS or TRT during this window reset the fertility clock. Proactive symptom management through the protocol itself, along with physician support, is the most effective strategy for bridging this gap.
What Blood Tests and Semen Analysis Should I Monitor During Spermatogenesis Recovery?
Recovery from androgen-induced infertility involves significant hormonal shifts. Objective monitoring is not optional - it guides dosing adjustments and catches complications early. Here is the monitoring matrix recommended in the clinical literature:Marker | Purpose | Frequency |
Total Testosterone | Assess HPG axis recovery and HCG dose-response in Leydig cells | Baseline, month 3, month 6 |
LH and FSH | Confirm endogenous pituitary signaling is resuming post-HCG | At cessation of HCG; then every 3 months |
Estradiol (E2) | Monitor T:E ratio; AI intervention threshold is T:E below 10:1 | Every 3 months |
Semen Analysis (SA) | Primary outcome measure; confirms spermatogenic response | Baseline, then every 2 months |
Hematocrit | TRT and HCG can raise red blood cell production; threshold 54% is absolute | Baseline, month 3, month 6 |
PSA (men over 40) | Monitor prostate stimulation from rising testosterone | Baseline, 12 months |
DiscountedLabs.com offers a post-PCT panel that covers the key markers in a single draw. Having baseline values before the protocol starts is critical for tracking progress and making decisions about dose escalation or adding FSH.
If sperm counts fail to improve after three to four months despite adequate testosterone response to HCG, this is a signal to either escalate to HCG + rFSH, or - if still on TRT - to discontinue testosterone and allow endogenous pituitary function to resume.
What Lifestyle Factors Support Spermatogenesis Recovery?
Pharmacological protocols are the primary driver of recovery, but several lifestyle factors either accelerate or blunt the response:• Sleep: Testosterone production is heavily dependent on sleep quality and quantity. Seven to nine hours of uninterrupted sleep is non-negotiable during HPG axis recovery. Even mild sleep restriction reduces LH pulse amplitude overnight.
• Exercise: Moderate aerobic activity (150 minutes per week) and twice-weekly resistance training support metabolic health and mood without over-stressing the HPA axis. Avoid excessive endurance training, which can suppress the HPG axis independently.
• Zinc: At 30-50 mg daily, zinc is specifically relevant for men with marginal deficiency. Zinc is a co-factor in testosterone biosynthesis and sperm maturation. Do not megadose without testing for deficiency first.
• Vitamin D: Deficiency is directly associated with lower testosterone and impaired steroidogenesis. Target serum 25-OH-D levels of 50-80 ng/mL during recovery; supplementation at 2,000-4,000 IU daily is appropriate for most deficient men.
• Heat avoidance: Spermatogenesis requires scrotal temperatures below core body temperature. Avoid hot baths, saunas, and prolonged laptop use on the lap during recovery.
• Alcohol and cannabis: Both suppress testosterone and directly impair sperm quality. Minimizing or eliminating use during the recovery window is advisable.
Frequently Asked Questions
How soon can I expect my sperm count to improve after starting HCG?
With HCG combined with FSH or a SERM, the average time to initial spermatogenic response is approximately 4.6 months. Early signs - small numbers of sperm appearing in a previously azoospermic sample - often precede meaningful count improvements. Most clinicians recommend semen analysis at 2-month intervals during the protocol. Do not make clinical decisions based on a single result, as sperm counts fluctuate significantly week to week.Can I restore fertility after years of testosterone use?
Yes, in the majority of cases. The 2024 Fertility and Sterility study included men with extended TRT histories, and 74% showed measurable improvement. However, longer TRT duration and older age (over 60) are associated with slower and less complete recovery. Men who have been on TRT for over two years may require longer protocols or higher doses. Ten to twenty percent of men do not recover normal spermatogenesis without pharmacological support even after stopping TRT - underscoring why proactive HCG maintenance during TRT, or sperm banking before starting, is valuable insurance.Is enclomiphene better than clomiphene for HPTA recovery?
Enclomiphene appears to offer comparable efficacy with fewer estrogenic side effects, making it a preferred option for men who cannot tolerate standard clomiphene. Clomiphene contains both the enclomiphene isomer (anti-estrogenic) and zuclomiphene (estrogenic), and the latter is responsible for mood disturbances and visual side effects in a subset of men. Enclomiphene is not currently FDA-approved in the US, and regulatory status should be confirmed with your physician. For men who are intolerant of both SERMs, HCG combined with rFSH is a viable and often superior alternative.Should I bank sperm before starting TRT?
Yes, if you have any possibility of wanting biological children in the future. Sperm banking is the only guaranteed fertility insurance. Even if you plan to use HCG throughout TRT, sperm counts can decline in 10-33% of men despite consistent HCG use. Banking a sample before your first testosterone injection eliminates all future uncertainty, is relatively inexpensive, and requires only one clinic visit. The ExcelMale community strongly recommends this approach, and many knowledgeable TRT physicians now make it a routine pre-TRT recommendation.What if pharmacological treatment fails to restore my sperm count?
For men who do not respond to standard HCG + FSH or HCG + SERM protocols, several options remain. First, the protocol should be escalated: higher HCG doses, switching from SERM to rFSH, or discontinuing TRT entirely to allow full pituitary reactivation. Second, if baseline semen analysis showed cryptozoospermia (rare sperm present but below counting thresholds), testicular sperm extraction (TESE) or microdissection TESE (m-TESE) can retrieve sperm directly from testicular tissue for use in IVF/ICSI - even in men with persistent azoospermia. A specialist reproductive urologist or andrologist is essential at this stage.Related ExcelMale Forum Discussions
• Recovery of Sperm Production Following Testosterone Replacement or Anabolic Steroids - Clinical summaries and treatment algorithms from the medical literature, curated by Nelson Vergel.• How Does HCG Therapy Restore Sperm Production After TRT Suppresses It? - A detailed breakdown of the 2024 Fertility and Sterility data and dosing evidence, including the landmark finding that staying on TRT does not impede HCG/FSH recovery.
• Fertility Maintenance or Restoration in Men Before, During, and After TRT or AAS - Comprehensive review covering prevention, maintenance, and active restoration protocols based on published clinical guidelines.
• How to Improve Sperm Quality, LH, FSH and Testosterone in Infertile Men - First-hand community accounts from men who restored fertility using HCG, HMG, and FSH protocols, including cases involving decades of TRT.
• Best HCG Dose for Men on TRT: Two Studies That Used HCG with Testosterone - Evidence review showing why 500 IU (not 250 IU) is the minimum dose to maintain intratesticular testosterone while on TRT.
• Clomid to Reset Hormonal Axis After Anabolic Steroids - Discusses the first published case of clomiphene successfully restoring testosterone and pituitary-gonadal axis function after multi-anabolic steroid abuse.
• HPTA Restart in Young Men After Anabolic Steroids - Specific guidance and community discussion for younger men (under 35) seeking hormonal recovery after AAS use.
• How to Stop Testosterone or Anabolics Safely - What PCT Programs Work? - Extensive thread covering multiple PCT frameworks including the Dr. Scally protocol, with community member recovery logs.
• Regaining Fertility After 3 Years TRT - Real member experiences navigating fertility protocols after extended TRT use, including practical observations on HCG dosing and timing.
• Why Use HCG with TRT? A Clinical Review - In-depth overview of the HPG mechanisms behind HCG's role in TRT, including evidence on ITT maintenance, testicular atrophy prevention, and fertility outcomes.
Key References
1. McBride JA, Coward RM. Recovery of Spermatogenesis Following Testosterone Replacement Therapy or Anabolic-Androgenic Steroid Use. Asian Journal of Andrology. 2016. [Link]2. Hsieh TC, et al. Concomitant Intramuscular Human Chorionic Gonadotropin Preserves Spermatogenesis in Men Undergoing Testosterone Replacement Therapy. Journal of Urology. 2013. DOI: 10.1016/j.juro.2012.08.084 [Link]
3. Coviello AD, et al. Low-Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men with Testosterone-Induced Gonadotropin Suppression. Journal of Clinical Endocrinology and Metabolism. 2005. DOI: 10.1210/jc.2004-0802 [Link]
4. Kannady C, et al. Optimal Restoration of Spermatogenesis After Testosterone Therapy Using Human Chorionic Gonadotropin and Follicle-Stimulating Hormone. Fertility and Sterility. 2024. DOI: 10.1016/j.fertnstert.2024.08.358 [Link]
5. Kohn TP, et al. Fertility Outcomes After Testosterone Replacement Therapy or Anabolic Steroid Abuse. Journal of Urology. 2018. DOI: 10.1016/j.juro.2017.10.019 [Link]
6. Handelsman DJ, et al. Recovery of Male Reproductive Function After Ceasing Prolonged Testosterone Undecanoate Injections. European Journal of Endocrinology. 2022. DOI: 10.1530/EJE-21-0608 [Link]
7. Thomas J, et al. Efficacy of Clomiphene Citrate Versus Enclomiphene Citrate for Male Infertility Treatment: A Retrospective Study. Cureus. 2023. DOI: 10.7759/cureus.41476 [Link]
8. Ramasamy R, et al. Factors Predicting Normalization of Reproductive Hormones After Cessation of AAS in Men. World Journal of Men's Health. 2019. DOI: 10.5534/wjmh.190002 [Link]
9. Injac R. Spermatogenesis Recovery Treatment in Less Than Four Months After Several Cycles of Steroids. Clinical Case Reports. 2023. DOI: 10.1002/ccr3.8159 [Link]
10. WHO Task Force on Methods for the Regulation of Male Fertility. Contraceptive Efficacy of Testosterone-Induced Azoospermia in Normal Men. Lancet. 1990. [Link]
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or modifying any hormone therapy, fertility protocol, or medical treatment. The protocols described here are based on published clinical literature and should be implemented only under physician supervision, with appropriate laboratory monitoring.
About ExcelMale.com
ExcelMale.com is the leading expert-moderated men's health forum, with over 24,000 members and a 20-year archive of evidence-based discussion on testosterone replacement therapy, hormone optimization, peptides, sexual health, and metabolic wellness. Founded by Nelson Vergel - chemical engineer, 34-year TRT patient, and patient advocate - the community bridges clinical research with real-world patient experience.
Nelson is the author of Testosterone: A Man's Guide and Beyond Testosterone, both available on Amazon. For laboratory testing, visit DiscountedLabs.com for affordable male hormone and fertility panels.
Last edited:
